In CMS
Jan 25th, 2018
Former drug industry executive, Alex Azar, was confirmed by congress by bipartisan vote to be the new secretary of the U.S. Department of Health & Human Services (HHS). The former president of the Big Pharma company Eli Lilly & Co., “will now be in charge of buying more medications than anyone in the world,” according ...
The Medicare Payment Advisory Commission’s (MedPAC) June Report to the Congress addresses (among other things) issues it sees with the Merit-based Incentive Payment System (MIPS) — one of two paths in the Centers for Medicare & Medicaid Services’ (CMS) Quality Payment Program, and a provision of the Medicare Access and CHIP Reauthorization Act (MACRA). “As ...
Mar 6th, 2017
During a Joint Address to Congress, Feb. 28, President Trump called on Democrats and Republicans to repeal and replace Obamacare with reforms that expand choice, increase access, lower costs, and provider better healthcare. “Mandating every American to buy government-approved health insurance was never the right solution for our country,” Trump said. “The way to make health insura...
Dec 7th, 2016
The hospital industry wants President-elect Donald Trump and congressional leaders to preserve coverage gains when repealing the Affordable Care Act (ACA) and, if not, they want legislators to repeal funding reductions for hospital services in the ACA. In a letter to the incoming administration and another to Congress, the American Hospital Association (AHA) and Federation of American ...
Nov 21st, 2015
The United States and New Zealand are the only countries in the world that allow direct advertising of prescription drugs to consumers. In the U.S., the American Medical Association (AMA) wants to change that, and voted at their 2015 Interim Meeting in Atlanta to do so. In a press release on November 17, AMA Board Chair-elect Patrice Harris, M.D., said, ...